Michael J Cuttica1, Laura A Colangelo2, Sanjiv J Shah2, Joao Lima3, Satoru Kishi3, Alexander Arynchyn4, David R Jacobs5, Bharat Thyagarajan6, Kiang Liu7, Donald Lloyd-Jones2,7, Ravi Kalhan1,7. 1. 1 Division of Pulmonary and Critical Care Medicine. 2. 2 Division of Cardiology, and. 3. 3 Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 4. 4 Division of Preventive Medicine, University of Alabama, Birmingham, Alabama; 5. 5 Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota; and. 6. 6 Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, Minnesota. 7. 7 Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois;
Abstract
RATIONALE: Chronic lung diseases are associated with cardiovascular disease. How these associations evolve from young adulthood forward is unknown. Understanding the preclinical history of these associations could inform prevention strategies for common heart-lung conditions. OBJECTIVES: To use the Coronary Artery Risk Development in Young Adults (CARDIA) study to explore the development of heart-lung interactions. METHODS: We analyzed cardiac structural and functional measurements determined by echocardiography at Year 25 of CARDIA and measures of pulmonary function over 20 years in 3,000 participants. MEASUREMENTS AND MAIN RESULTS: Decline in FVC from peak was associated with larger left ventricular mass (β = 6.05 g per SD of FVC decline; P < 0.0001) and greater cardiac output (β = 0.109 L/min per SD of FVC decline; P = 0.001). Decline in FEV1/FVC ratio was associated with smaller left atrial internal dimension (β = -0.038 cm per SD FEV1/FVC decline; P < 0.0001) and lower cardiac output (β = -0.070 L/min per SD of FEV1/FVC decline; P = 0.03). Decline in FVC was associated with diastolic dysfunction (odds ratio, 3.39; 95% confidence interval, 1.37-8.36; P = 0.006). CONCLUSIONS: Patterns of loss of lung health are associated with specific cardiovascular phenotypes in middle age. Decline in FEV1/FVC ratio is associated with underfilling of the left heart and low cardiac output. Decline in FVC with preserved FEV1/FVC ratio is associated with left ventricular hypertrophy and diastolic dysfunction. Cardiopulmonary interactions apparent with common complex heart and lung diseases evolve concurrently from early adulthood forward.
RATIONALE: Chronic lung diseases are associated with cardiovascular disease. How these associations evolve from young adulthood forward is unknown. Understanding the preclinical history of these associations could inform prevention strategies for common heart-lung conditions. OBJECTIVES: To use the Coronary Artery Risk Development in Young Adults (CARDIA) study to explore the development of heart-lung interactions. METHODS: We analyzed cardiac structural and functional measurements determined by echocardiography at Year 25 of CARDIA and measures of pulmonary function over 20 years in 3,000 participants. MEASUREMENTS AND MAIN RESULTS: Decline in FVC from peak was associated with larger left ventricular mass (β = 6.05 g per SD of FVC decline; P < 0.0001) and greater cardiac output (β = 0.109 L/min per SD of FVC decline; P = 0.001). Decline in FEV1/FVC ratio was associated with smaller left atrial internal dimension (β = -0.038 cm per SD FEV1/FVC decline; P < 0.0001) and lower cardiac output (β = -0.070 L/min per SD of FEV1/FVC decline; P = 0.03). Decline in FVC was associated with diastolic dysfunction (odds ratio, 3.39; 95% confidence interval, 1.37-8.36; P = 0.006). CONCLUSIONS: Patterns of loss of lung health are associated with specific cardiovascular phenotypes in middle age. Decline in FEV1/FVC ratio is associated with underfilling of the left heart and low cardiac output. Decline in FVC with preserved FEV1/FVC ratio is associated with left ventricular hypertrophy and diastolic dysfunction. Cardiopulmonary interactions apparent with common complex heart and lung diseases evolve concurrently from early adulthood forward.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr Journal: Am J Respir Crit Care Med Date: 2009-06-19 Impact factor: 21.405
Authors: Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Courtney Crim; Lisa R Willits; Julie C Yates; Jørgen Vestbo Journal: Thorax Date: 2010-08 Impact factor: 9.139
Authors: Suellen M Curkendall; Cynthia DeLuise; Judith K Jones; Stephan Lanes; Mary Rose Stang; Earl Goehring; Dewei She Journal: Ann Epidemiol Date: 2005-07-21 Impact factor: 3.797
Authors: R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson Journal: N Engl J Med Date: 2010-01-21 Impact factor: 91.245
Authors: Keiichi Sumida; Lucia Kwak; Morgan E Grams; Kunihiro Yamagata; Naresh M Punjabi; Csaba P Kovesdy; Josef Coresh; Kunihiro Matsushita Journal: Am J Kidney Dis Date: 2017-07-26 Impact factor: 8.860
Authors: Charles Antwi-Boasiako; Michael M Asare; Ibrahim Baba; Alfred Doku; Kevin Adutwum-Ofosu; Charles Hayfron-Benjamin; Chamila P Asare; Robert Aryee; Gifty Boatemaah Dankwah; John Ahenkorah Journal: Am J Blood Res Date: 2021-04-15
Authors: Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan Journal: Am J Respir Crit Care Med Date: 2018-08-15 Impact factor: 21.405
Authors: Sherri Lynne Katz; Thuy Mai Luu; Anne-Monique Nuyt; Thierry Lacaze; Kristi Brae Adamo; Ian Adatia; Tilman Humpl; Robert Peter Jankov; Theo J Moraes; Katharina Staub; Michael K Stickland; Bernard Thebaud Journal: Paediatr Child Health Date: 2017-04-17 Impact factor: 2.253
Authors: Lillian R Benck; Michael J Cuttica; Laura A Colangelo; Stephen Sidney; Mark T Dransfield; David M Mannino; David R Jacobs; Cora E Lewis; Na Zhu; George R Washko; Kiang Liu; Mercedes R Carnethon; Ravi Kalhan Journal: Am J Respir Crit Care Med Date: 2017-05-01 Impact factor: 30.528